Acrevit-DPF Tablet
Marketer
Accretion Pharmaceuticals
Salt Composition
Doxylamine (20mg) + Vitamin B6 (Pyridoxine) (20mg) + Folic Acid (5mg)
Overview Acrevit-DPF Tablet
Dovigen-N tablets combine medications to alleviate pregnancy-related nausea and vomiting. This medication works by interrupting the transmission of nausea-inducing signals to the brain. Dovigen-N should be taken as directed by your physician, with or without food. Dosage is tailored to your individual needs and response. Continue treatment for the prescribed duration; premature discontinuation may lead to symptom recurrence and potential worsening of your condition. Inform your doctor of all other medications you are using, as interactions are possible. Common side effects include dry mouth, constipation, and mild dizziness. These are usually transient and self-limiting. Report any concerning side effects immediately to your doctor. Drowsiness and dizziness are potential side effects; refrain from driving or tasks requiring alertness until you assess your response. Alcohol consumption should be avoided while using this medication due to potential increased drowsiness.
Uses of Acrevit-DPF Tablet
Managing nausea and vomiting during pregnancy
Major Benefits of Acrevit-DPF Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Consume Acrevit-DPF Tablet with food.
Common Side effects of Acrevit-DPF Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Dryness in mouth
- Constipation
How to use Acrevit-DPF Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; do not crush, chew, or fracture it. It's recommended to take Acrevit-DPF Tablet with food.
How Acrevit-DPF Tablet works:
Doxylamine, pyridoxine (vitamin B6), and folic acid combine in Acrevit-DPF tablets to alleviate pregnancy-related nausea and vomiting.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Acrevit-DPF Tablet with alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
Using Acrevit-DPF tablets during pregnancy is considered safe. Research generally indicates minimal or no hazard to the fetus.
Breast feedingSAFE IF PRESCRIBED
The use of Acrevit-DPF Tablets during breastfeeding is likely safe. Available data from humans indicate minimal risk to the infant. However, higher dosages or extended Acrevit-DPF Tablet use could potentially induce drowsiness or other effects in the nursing child.
DrivingUNSAFE
Taking Acrevit-DPF tablets may cause drowsiness, blurred vision, or dizziness, potentially impairing alertness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
The use of Acrevit-DPF Tablets in individuals with kidney disease is likely safe. Preliminary evidence indicates dose modification may be unnecessary, however, medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Acrevit-DPF Tablets in individuals with liver conditions appears to pose minimal risk. Current evidence indicates dose modification may not be necessary; however, physician consultation is recommended.
What if you forget to take Acrevit-DPF Tablet :
Should you forget to take your Acrevit-DPF Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Acrevit-DPF Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Digestive System |



